Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Childrens Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..
Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.
Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Childrens Research Institute. Her current research interest is aimed at extending the use of cord...
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Childrens Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..
Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.
Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Top Publications
Elwood, NJ, Jiang, X-R, Chiu, C-P, Lebkowski, JS, Smith, CA.
Enhanced long-term survival, but no increase in replicative capacity, following retroviral transduction of human cord blood CD34+ cells with human telomerase reverse transcriptase..
Haematologica
89(3)
:
377 -378
2004
view publication
Elwood, NJ, Smith, CA.
Current Status of Retroviral Vector Mediated Gene Transfer into Human Hematopoietic Stem Cells.
Leukemia & Lymphoma
41(5-6)
:
465 -482
2001
view publication
Elwood, NJ, Smith, CA.
Current Status of Retroviral Vector Mediated Gene Transfer into Human Hematopoietic Stem Cells.
Leukemia & Lymphoma
41(1-2)
:
1 -18
2001
view publication
Dawson, MJ, Elwood, NJ, Johnstone, RW, Trapani, JA.
The IFN‐inducible nucleoprotein IFI 16 is expressed in cells of the monocyte lineage, but is rapidly and markedly down‐regulated in other myeloid precursor populations.
Journal of Leukocyte Biology
64(4)
:
546 -554
1998
view publication
Elwood, NJ, Zogos, H, Pereira, DS, Dick, JE, Begley, CG.
Enhanced Megakaryocyte and Erythroid Development From Normal Human CD34+ Cells: Consequence of Enforced Expression of SCL.
Blood
91(10)
:
3756 -3765
1998
view publication